In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

WASHINGTON >> President Joe Biden today proposed expanding coverage of anti-obesity drugs, like Novo Nordisk’s Wegovy, for more than 7 million people with Medicare and Medicaid health coverage, which ...

US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines ...

Injection Pen Market. The global injection pen market is on track for substantial growth, with a forecasted compound annual ...

Novo Nordisk’s amylin ... However, I believe Nordisk can pull it off, because the company has an incredible track record. And let’s not forget that it is the global leader in diabetes treatments ...

Three-fourths of U.S. adults are now overweight or have obesity, with nearly 260 million predicted to have overweight or ...

Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...

Doctors Without Borders, also known as Médecins Sans Frontières (MSF), and organisations representing people with diabetes ...

About 400 people marched to the South African headquarters of Novo Nordisk ... insulin and lower prices, while also protesting against the Danish company’s recent decision to phase out easy-to ...